U.S. Personal Mobility Devices Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2031)

U.S. Personal Mobility Devices Market Trends and Insights

Aging U.S. Population and Rising Mobility-Loss Years Lived

Motor function impairments among older Americans show a steep age-related pattern. Chair-stand impairments are significant in the 65 to 69 age group, while gait-speed issues dominate among those aged 90 and above.^{[2]Centers for Disease Control and Prevention, “Disability and Health Data,” CDC, cdc.gov} The next wave of retirees carries heavier disability burdens from middle age, leading to earlier adoption of mobility aids. Rising musculoskeletal disorders and fall-related mortalities among adults aged 65 and older indicate increasing reliance on powered support. This trend sustains replacement demand and ties the United States personal mobility devices market to demographic shifts rather than short-term care cycles.

High Disability and Arthritis Burden Expanding Addressable Users

Stroke and osteoarthritis are key drivers of wheelchair and scooter use in the United States, broadening the user base across age groups and care settings. A 2024 study of 64.1 million adults with arthritis found that age over 70, severe pain, and comorbidities significantly limit physical functioning, creating a large pool of intermittent and permanent device users.^{[3]PLOS One, “Cohort Patterns in Disability Burden,” PLOS One, plos.org} The disability share of the United States population rose to 14.14% in 2024, marking a second consecutive year of increase. This growing user base favors lightweight, foldable, and mid-range devices, positioning suppliers with diverse inventories to capture market growth.

Medicare Coverage Breadth and Seat-Elevation Reimbursement Update

CMS now recognizes power seat elevation equipment as reimbursable durable medical equipment for eligible wheelchair users, enhancing the commercial appeal of high-spec chairs and accessories. This policy influences commercial insurers and Medicaid, which often align with CMS standards. From January 1, 2025, CMS reduced the prior authorization review period for DMEPOS items to 7 days, expediting product delivery.^{[4]Centers for Medicare & Medicaid Services, “National Coverage Determination 280.16,” CMS, cms.gov} Additionally, CMS introduced a prior authorization exemption in December 2025 for compliant suppliers, giving an operational edge to vendors with strong documentation and EHR workflows in the United States personal mobility devices market.

Shift to Lighter, Foldable, Connected Power Mobility Platforms

The United States personal mobility devices market is rapidly evolving with manufacturers adopting advanced materials like titanium and aircraft-grade aluminum, along with lithium-ion batteries and app-based controls. In 2026, Permobil launched TiLite TR and TiLite ZR titanium wheelchairs, offering lighter components and enhanced customization for improved manual performance. Sunrise Medical introduced the Empulse M90 wheel add-on in 2025, enabling motorized propulsion for manual wheelchair users. Regulatory acceptance of connected mobility features, such as app-controlled operations, is growing, driving demand for products that combine portability, convenience, and clinical performance.

High Out-of-Pocket Burden for Advanced Powered Devices

Advanced complex rehabilitative power wheelchairs often exceed USD 30,000, with Medicare covering only a portion of the cost and secondary insurance varying widely. A 2025 disability-rights survey revealed that Medicare users faced partial reimbursements, delays, and significant out-of-pocket expenses, leading to increased pain, reduced activity, and social isolation. In 2024, the poverty rate for working-age adults with disabilities was 24.8%, compared to 11.1% for non-disabled adults, highlighting financial barriers to accessing premium devices. 

Safety Recalls & Rising Litigation on Lithium-ion Fire Risk

Lithium-ion battery thermal runaway remains a key compliance risk in the United States personal mobility devices market, leading to recalls, legal challenges, and higher engineering costs. In April 2026, the FDA issued a Class 1 recall for WHILL Model F powered wheelchairs due to software faults increasing patient harm risks. Similarly, in June 2025, the FDA announced a Class 2 recall for Mobius Mobility’s iBOT PMD, requiring field corrections. While ISO standards emphasize battery safety, compliance inconsistencies persist, particularly outside specialist channels. Budget brands and low-cost scooters face greater risks of service disruptions and liability compared to premium suppliers with advanced battery management systems.

Segment Analysis

By Product Type: Power Platform Diversification Reshaping the Category Mix

In 2025, wheelchairs accounted for 45.21% of the United States personal mobility devices market, driven by established reimbursement pathways and urgent clinical needs. Manual and complex rehabilitative power wheelchairs remain key, while power wheelchairs are gaining traction due to expanded coverage and improved designs. Mobility scooters, with a projected CAGR of 6.66% from 2026 to 2031, cater to ambulatory users needing enhanced community and outdoor mobility. Walking aids, including canes, crutches, walkers, and rollators, maintain steady demand due to affordability and ease of purchase. The category mix is evolving as buyers increasingly opt for power-assist and positioning add-ons instead of transitioning directly to powered chairs. Sunrise Medical’s Empulse M90 enables cost-effective upgrades to manual chairs with motorized propulsion. 

By Technology: Connected Intelligence Accelerating Premium Tier Growth

Manual devices accounted for 50.45% of the technology split in 2025, reflecting the widespread use of manual wheelchairs, walkers, and rollators. Powered devices, projected to grow at a 7.12% CAGR from 2026 to 2031, are gaining popularity due to reduced self-propulsion ability, better reimbursement support, and higher comfort expectations. Power-assist and hybrid systems bridge the gap, offering motorized support without requiring a full transition to premium powered frames.

Advanced features are increasingly moving from specialized rehabilitation products to standard configurations. Sunrise Medical introduced Dynamic Controls LiNX controls in the QUICKIE Q300 M Mini, narrowing the gap between premium and mid-market products.

By End User: Homecare Migration Concentrating Commercial Opportunity

In 2025, personal users and households represented 58.40% of the end-user segment, reflecting a shift toward home-based mobility support. Home healthcare and DME rental providers, projected to grow at an 8.10% CAGR from 2026 to 2031, are driving demand as post-acute care increasingly moves to residential settings. Products like walkers, rollators, entry-level scooters, and lower-acuity wheelchairs align with this trend due to their quick deployment in households.

Institutional channels remain significant, particularly in long-term care and assisted living, where operators prioritize reliable supply over premium features. A 2025 Mayo Clinic Proceedings study revealed delays in Medicare-listed wheelchair supplier services, prompting some users to seek alternatives outside traditional referral chains.

By Distribution Channel: E-Commerce Acceleration Redefining DME Procurement

Offline channels held 69.77% of the market in 2025, emphasizing the importance of in-person assessments, insurance handling, and supplier-managed setups. E-commerce, with a projected CAGR of 9.05% from 2026 to 2031, is growing rapidly due to broader product assortments, easier comparisons, and better access in underserved areas. This growth is strongest for products requiring minimal clinical customization, such as walkers, canes, and lower-acuity scooters.

The channel shift is uneven, as products requiring CMS prior authorization or complex fittings still favor offline distribution. Lower-acuity products benefit from the privacy and convenience of online ordering, especially in rural markets.

Geography Analysis

Demand in the United States personal mobility devices market varies regionally due to differences in age demographics, disability prevalence, reimbursement access, service density, and housing conditions. The South, led by Florida, Texas, Arizona, and the broader Sun Belt corridor, remains the highest-demand zone. A growing retiree population and aging demographics drive demand for scooters, wheelchairs, and accessories across reimbursed and self-pay channels. Warm climates and retirement migration further boost the need for outdoor mobility devices, keeping the South central to volume demand despite state-specific product preferences.

The Northeast presents a distinct profile, with dense hospital networks, rehabilitation centers, and urban care systems driving institutional demand for transport chairs, advanced rehabilitative power devices, and seating systems. Compact city environments have historically limited outdoor mobility use, but foldable and travel-safe powered devices now offer urban users improved transit compatibility and home storage flexibility.

Western states, including California and Washington, lead in adopting connected and smart mobility devices, supported by a tech-savvy senior population and proximity to innovation hubs. These markets favor premium manual frames, app-integrated controls, and lifestyle-oriented powered products, reflecting consumer willingness to invest in portability and design.